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Biopsy-proven kidney disease has been reported glob-
ally. Some of these data are based upon nationwide renal 
biopsy registries, while single-center-based data have 
also been provided from countries without registry co-
horts. Because of the heterogeneity of study populations 
and numerous confounding components in retrospective 
studies, conclusions on the frequencies of renal diseases 
are not simple. 
Definitions, diagnostic criteria, and terminologies in re-
nal pathology have changed over the years. For instance, 
“mesangioproliferative glomerulonephritis (MsPGN)” is 
a descriptive term indicating increased number of me-
sangial cells but is not a disease entity. According to the 
underlying etiology, MsPGN could be further classified 
as immunoglobulin A (IgA) nephropathy, lupus nephri-
tis, C3 glomerulopathy, and so on. Therefore, analyses 
using the term MsPGN in previous studies [1,2] cannot 
be directly compared to other reports using refined ter-
minologies. Secondly, indications for performing renal 
biopsy in patients suspected of kidney disease are quite 
different among countries, institutions, and even clini-
cians. In each country, socioeconomic status and health 
policies may affect clinicians’ decision making. Patient 
demographics, including age at biopsy, have tremendous 
impact on the frequencies of renal diseases. Therefore, 
readers should keep these things in mind when they 
compare the results of studies. 
Table 1 summarizes the previous publications on fre-
quencies of biopsy-proven renal diseases reported in 
China, Japan, and South Korea [1-9]. These data show 
major biopsy-proven glomerular diseases in East Asian 
countries. China has a huge population, and even a sin-
gle-center study contains many biopsy cases. Japan and 
Korea have employed a regular mass screening of urine 
from primary school to high school since 1973 and 1998, 
respectively, for early detection of renal diseases [10]. 
This program might have affected the performance of re-
nal biopsy. 
In this issue of Kidney Research and Clinical Practice, 
Yim et al [9] report another study on the frequencies of 
renal diseases confirmed by renal biopsy in South Ko-
rea. This analysis was based on a retrospective review of 
1,924 renal biopsy results from a single tertiary university 
hospital. After excluding pediatric cases (age < 15 years) 
and kidney allograft biopsies, the most common primary 
glomerular disease was IgA nephropathy, and the most 
common secondary glomerulopathy was lupus nephritis. 
Minimal change disease was most frequently diagnosed 
in patients who were biopsied because of nephrotic syn-
drome. 
Similar to other studies, this study has both weaknesses 
and strengths. Although the study comprised 13 years’ 
experience at a single institution, the size of the study 
population was smaller than those of Chinese studies. 
Furthermore, the data and their interpretation were less 
refined than those of Japanese studies based upon the 
national renal biopsy registry. However, this study offers 
several interesting findings. IgA nephropathy was most 
prevalent in younger patients, whereas membranous ne-
The spectrum of biopsy-proven renal diseases in Korea
Beom Jin Lim
Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea
Editorial  KIDNEY RESEARCH
AND CLINICAL PRACTICE
Received January 30, 2020; Revised February 2, 2020;  
Accepted February 3, 2020
Edited by Gheun-Ho Kim, Hanyang University, Seoul, Republic of 
Korea
Correspondence: Beom Jin Lim 
Department of Pathology, Yonsei University College of Medicine, 
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea. 
E-mail: bjlim@yuhs.ac
Copyright © 2020 by The Korean Society of Nephrology 
CC  This is an open-access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc-nd/4.0/), which permits unrestricted non-commercial 
use, distribution, and reproduction in any medium, provided the original work 
is properly cited.
Kidney Res Clin Pract 2020;39(1):1-3
pISSN: 2211-9132 • eISSN: 2211-9140
https://doi.org/10.23876/j.krcp.20.019
2 www.krcp-ksn.org
phropathy was the dominant disease in elderly patients 
regardless of clinical presentation. The most frequently 
diagnosed glomerular disease in patients with hepatitis B 
or C seropositivity was IgA nephropathy rather than cryo-
globulinemic glomerulonephritis. 
Although these data cannot be assumed to be repre-
sentative of the Korean population, the results are largely 
compatible with previous studies from Korean patients 
[1,3,4]. In the current study, thin basement membrane 
disease previously had an exceptionally high frequency 
but dramatically declined in recent years. As discussed in 
their interpretation, the indications for renal biopsy vary 
according to time period and institution. Over a certain 
period of time, renal biopsies might have been actively 
performed in young males who showed asymptomatic 
minor urinary abnormalities as qualification for mili-
tary service. The fluctuating frequency of thin basement 
membrane disease and relatively younger age of this co-
hort could explain this unique finding.
Recent studies from China showed that membranous 
nephropathy is increasing [6,11], and this result might 
be associated with air pollution by particulate matter 2.5 
(PM2.5) [12]. However, the current study [9] did not show 
any significant change in frequency of membranous ne-
phropathy according to time course. Because the Korean 
study analyzed data until 2013 only, it is necessary to col-
lect more recent cases and compare them with those of 
China.
As expected, a nationwide renal biopsy registry had 
many beneficial effects, including more reliable analyses 
of disease frequencies by coding the diagnoses in each 
institution and more reasonable clinicopathological 
correlations [13]. Future studies should be based on na-
tionwide or multinational renal biopsy registries. An East 
Asian regional renal biopsy registry could be constructed 
by collaborative nephrologists in China, Japan, and Ko-
rea. 
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cause of nephrotic 
syndromeAdults Children KT




MCD (adults  
and children)
Chang et al [4] 2009 Korea No 1,818 O X X IgAN Lupus nephritis MCD
Shin et al [1] 2017 Korea No 818 O X X MsPGN Lupus nephritis
Zhang et al [5] 2014 China No 11,618 O O X IgAN Lupus nephritis
Zhou et al [2] 2018 China No 10,779 O X X IgAN Lupus nephritis
Su et al [6] 2019 China No 2,725 O X X MN HSPN MN
Sugiyama et al [7] 2011 Japan Yes 2,400 O O O IgAN Diabetic nephropathy
Yokoyama et al [8] 2012 Japan Yes 2,802 O (elderly) X X MN ANCA-related nephritis MN
Yim et al [9] 2020 Korea No 1,924 O X X IgAN Lupus nephritis MCD
ANCA, antineutrophil cytoplasmic antibody; GN, glomerulonephritis; HSPN; Henoch-Schönlein purpura nephritis; IgAN, immunoglobulin A nephropathy; KT, kidney 
transplantation; MCD, minimal change disease; MN, membranous nephropathy; MsPGN, mesangioproliferative glomerulonephritis.
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